As a fully integrated supplier, Biotest covers the entire value chain for drug manufacturing – from pre-clinical and clinical development of new products and from collecting plasma as the core raw material for plasma protein products, to manufacturing, marketing and global sales.
Products
Currently Biotest markets 14 different products in three therapeutic areas in clinical immunology, haematology and intensive care medicine, further are in the pipeline.